Vikram Karnik Profile
Vikram Karnik

@vkarnik1

Followers
386
Following
2K
Statuses
441

Neurologist, Adult Neurology Residency Program Director, Movement Disorders Specialist @DCNSNeuro

Joined October 2010
Don't wanna be here? Send us removal request.
@vkarnik1
Vikram Karnik
7 days
RT @draravindganesh: Lab members @WilliamBetzner and Raksha Ramkumar killing it at ISC2025 @StrokeAHA_ASA discussing how to think about mea…
0
6
0
@vkarnik1
Vikram Karnik
2 months
RT @SarahLidstone: I’m thrilled to announce that my TEDx Talk is now live! I dive into how our brains, minds and body work together to shap…
0
35
0
@vkarnik1
Vikram Karnik
2 months
RT @UCalgary: Congratulations to @FluidBiomed on securing one of the largest Series A funding rounds for a MedTech company in Canada! UCeed…
0
6
0
@vkarnik1
Vikram Karnik
2 months
RT @movedisorder: Welcome to Timothy Lynch and Davide Martino, who are the new incoming Co-Editors-in-Chief of the Movement Disorders Clini…
0
5
0
@vkarnik1
Vikram Karnik
2 months
RT @GreenJournal: Neurology Podcast: Dr. Vikram Karnik and Dr. Kate Wyman-Chick discuss distinguishing prodromal dementia with Lewy bodies…
0
4
0
@vkarnik1
Vikram Karnik
3 months
Awesome opportunity to learn from awesome people.
@amyyu_md
Amy Yu, MD
3 months
✏️ Reviewer-in-Training program with @JournalCJNS @CNSFNeuroLinks Are you a resident or fellow in neurosciences? Are you interested in learning about what happens once a manuscript is submitted to a journal? Check out this new opportunity 👉
Tweet media one
1
1
1
@vkarnik1
Vikram Karnik
3 months
Important literature on a potentially treatable ataxia.
@AMahajanMD
Abhimanyu Mahajan
3 months
Data on 102 SCA 27b patients from 5 centers Mean age of onset: 57 +/- 12.5y 21/28 patients responded to 4-AP “This finding offers the possibility of having a drug treatment that could be the L-dopa of ataxias,” said Dr. Gomez in ⁦@NeurologyToday
0
0
3
@vkarnik1
Vikram Karnik
3 months
RT @AMahajanMD: Data on 102 SCA 27b patients from 5 centers Mean age of onset: 57 +/- 12.5y 21/28 patients responded to 4-AP “This findin…
0
6
0
@vkarnik1
Vikram Karnik
3 months
@TMPringsheim @UCalgaryMed Congratulations Tamara!
0
0
0
@vkarnik1
Vikram Karnik
4 months
RT @JournalCJNS: #CJNS #PromotedArticle #FirstView -Long-Term Follow-Up of Non-Paraneoplastic Autoimmune Encephalitis: A Canadian Single-Ce…
0
3
0
@vkarnik1
Vikram Karnik
4 months
RT @NeurologyToday: Training programs on women’s issues in neurology have expanded to #headache, #CerebrovascularDisease, and more as they…
0
6
0
@vkarnik1
Vikram Karnik
4 months
RT @NeurologyToday: Classically trained pianist, flautist, and singer @emmakwoo has spent much of her life performing. Now, that outlet hel…
0
6
0
@vkarnik1
Vikram Karnik
5 months
@amyyu_md @HeartandStroke @BrainCanada @CIHR_IRSC Ha - they’d be lucky to have you as a mentor.
0
0
1
@vkarnik1
Vikram Karnik
5 months
RT @AMahajanMD: Our brief review on the management of #dystonia now online in @PracticalNeuro This effort was spearheaded by @UFMDC @Fixe
0
3
0
@vkarnik1
Vikram Karnik
5 months
RT @TashMisbah: Introducing 'UHURU' teaser 🎞️ I've witnessed the desperation & devastation caused by untreated Parkinson's in 🇰🇪 & 🇹🇿, and…
0
9
0
@vkarnik1
Vikram Karnik
6 months
RT @SCouttsMD: Human rights should never be ignored when choosing a conference location. The World Stroke congress should never have been h…
0
38
0
@vkarnik1
Vikram Karnik
6 months
RT @draravindganesh: 🚨 Is the modified Rankin Scale (mRS) the be-all, end-all of stroke trials, forever and ever? 😁As @johanna_ospel @mayan
0
16
0
@vkarnik1
Vikram Karnik
6 months
RT @UCalgaryMed: 👏🏽 Dr. Bijoy Menon’s stroke research has received a funding boost! Congrats to Dr. Menon, MD, whose nation-wide clinical t…
0
7
0
@vkarnik1
Vikram Karnik
7 months
RT @AMahajanMD: PD GENEration results in @Brain1878 ✅8301 individuals with PD with results from >85 centers ✅13% of all tested had a gene…
0
4
0